Cargando…
Hybridoma technology; advancements, clinical significance, and future aspects
BACKGROUND: Hybridoma technology is one of the most common methods used to produce monoclonal antibodies. In this process, antibody-producing B lymphocytes are isolated from mice after immunizing the mice with specific antigen and are fused with immortal myeloma cell lines to form hybrid cells, call...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521504/ https://www.ncbi.nlm.nih.gov/pubmed/34661773 http://dx.doi.org/10.1186/s43141-021-00264-6 |